IPOs

TELA Bio Files for $69 Million IPO
TELA Bio Files for $69 Million IPO
CP Wire
TELA Bio
IPOs
Ovitex
devices
Flag link:
TELA Bio Files for $69 Million IPO
TELA Bio
IPOs
Ovitex
devices
Flag link:
Eyeing $86M, Galera leads a pack of three modest biotech IPOs pushing past high profile stumbles
Eyeing $86M, Galera leads a pack of three modest biotech IPOs pushing past high profile stumbles
Endpoints
IPOs
Galera Therapeutics
89Bio
Centogene
Flag link:
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Motley Fool
biotech
IPOs
M&A
Flag link:
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More
Xconomy
Vir Biotechnology
IPOs
infectious diseases
Flag link:
Wall Street trims cancer drug developer BioNTech's unicorn valuation
Wall Street trims cancer drug developer BioNTech's unicorn valuation
Endpoints
NASDAQ
IPOs
BioNTech
Flag link:
Oyster Point Pharma Files for $85 Million IPO
Oyster Point Pharma Files for $85 Million IPO
CP Wire
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Flag link:
Oyster Point Pharma Files for $85 Million IPO
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Flag link:
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Xconomy
IPOs
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
ADC Therapeutics
Monopar Therapeutics
Flag link:
Cabaletta Bio Files for $100 Million IPO
Cabaletta Bio Files for $100 Million IPO
CP Wire
Cabaletta Bio
IPOs
autoimmune disease
DSG3-CAART
pemphigus vulgaris
Flag link:
Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO
Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO
CP Wire
4D Molecular Therapeutics
IPOs
gene therapy
Flag link:
Gene-Editing Company Beam Seeks $100 Million IPO
Gene-Editing Company Beam Seeks $100 Million IPO
BioSpace
Beam Therapeutics
IPOs
gene editing
Flag link:
Led by BioNTech, six biotechs line up for October IPOs
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Flag link:
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs
Xconomy
Beam Therapeutics
IPOs
CRISPR
Flag link:
Does amount matter when it comes to a biotech IPO?
Does amount matter when it comes to a biotech IPO?
EP Vantage
IPOs
biotech
NASDAQ
BioNTech
ADC Therapeutics
Flag link:
Frequency Therapeutics Updates $123 Million IPO Filing
Frequency Therapeutics Updates $123 Million IPO Filing
CP Wire
Frequency Therapeutics
IPOs
Flag link:
European biotech firm BioNtech plans to raise nearly $304 mln in U.S. IPO
European biotech firm BioNtech plans to raise nearly $304 mln in U.S. IPO
Yahoo/Reuters
Europe
IPOs
BioNTech
MRNA
Flag link:
Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO
Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO
Endpoints
Innate Pharma
IPOs
AstraZeneca
blood cancer
solid tumors
Flag link:
IPO take 2: Kindler's Centrexion restarts bid to fund pain trial
IPO take 2: Kindler's Centrexion restarts bid to fund pain trial
Fierce Biotech
Centrexion
IPOs
clinical trials
painkillers
CNTX-4975
osteoarthritis of the knee
Flag link:
3 Healthcare IPOs From 2018 That Have Already Doubled
3 Healthcare IPOs From 2018 That Have Already Doubled
Motley Fool
IPOs
Guardant Health
Allakos
Twist Bioscience
Flag link:

Pages